Stocks in news: Ambuja Cement, Alivus Life, Route Mobile, Aurobindo Pharma, LTIMindtree

Markets remained under pressure and ended with a loss of nearly one and a half percent on Tuesday, reflecting weak sentiment. In today's trade, shares of Ambuja Cement, Alivus Life, Route Mobile, Aurobindo Pharma, LTIMindtree among others will be in focus due to various news developments.

Piramal Enterprises
Piramal Enterprises announced that the administrative committee of its board of directors will meet on December 20 to consider public issuance of non-convertible debentures (NCDs).

VaTech Wabag

The tender for Saudi Arabia’s 300 MLD mega Sea Water Desalination Plant won by the company stands cancelled.

AB Capital
Vikas Gautam resigned as CEO - International Business of the Aditya Birla Sun Life AMC with effect from December 2024.

Alembic Pharma
Alembic Pharma issued a corporate guarantee of $10 million in favour of HSBC Bank, Chile for Chile-based arm Alembic Pharmaceuticals SpA.

Muthoot Capital
Muthoot Capital Services will consider issuance of non-convertible debentures (NCDs) on private placement basis on December 20.

Route Mobile
Route Mobile appointed Gautam Badalia as the CEO of the company with effect from December 2024.

LTIMindtree
LTIMindtree secured an interim stay on the tax order of Rs 88 crore from High Court Of Karnataka.

Glenmark Life Sciences
The ministry of corporate affairs (MCA) has approved a change in company’s name to Alivus Life Sciences with effect from December 17, 2024.

Aurobindo Pharma
The USFDA has issued two observations for the API unit of subsidiary Apitoria Pharma.

Exide Industries
Exide Industries has invested Rs 100 crore in arm Exide Energy Solutions (ESSL) on rights basis.